Antipsychotic drugs in mania: Factors predicting use of antipsychotic medication following inpatient treatment of mania

International Clinical Psychopharmacology

Volumn 19, Issue 5, 2004, Pages 291-297

  Samellas, Dimitris ^a   Read, Priscilla ^a   Cookson, John C ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Antipsychotics; Mania; Pharmacotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; LITHIUM; NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; MALE; MANIA; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 4344668878     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yic.0000132775.98340.b1     Document Type: Article

References (40)

1. Akiskal HS, Hantouche EG, Bourgeois ML, Azorin JM, Sechter D, Allilaire JF, et al. (1998). Gender, temperament, and the clinical picture of dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord 50:175-186.
2. American Psychiatric Association (1994). Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 151 (suppl 12):S1-S36.
3. Brecher M, Huizar K, El Baghdady A (2003). Quetiapine monotherapy for acute mania associated with bipolar disorder. Poster presented at the Fifth Annual International Conference on Bipolar Disorder, Pittsburgh, Pennsylvania, USA, 12-14 June.
4. Chou JC (1991). Recent advances in treatment of acute mania. J Clin Psychopharmacol II:3-21.
5. Chou JC, Zito JM, Vitral J, Craig TJ, Allingham BH, Czobor P (1996). Neuroleptics in acute mania: a pharmacoepidemiologic study. Annal Pharmacother 30:1396-1398.
6. Cookson JC (2001). Use of antipsychotic drugs and lithium in mania. Br J Psychiatry 178 (suppl 41):S148-S156.
7. Cookson JC (2004). Haloperidol and risperidone in mania. In: Akiskal H, Tohen M (editors): Bipolar pharmacotherapy: clinical management. Chichester: John Wiley and Sons, Ltd.
8. Cookson JC, Sachs GS (2000). Lithium: clinical use in mania and in prophylaxis of affective disorders. In: Buckley PF, Waddington JL (editors): Schizophrenia and mood disorders: the new drug therapies in clinical practice. Oxford: Butterworth Heinemann; pp. 155-178.
9. Cookson JC, Taylor D, Katona C (2002). Treatment of mania and bipolar disorders. In: Use of drugs in psychiatry. Trowbridge: Cromwell Press Ltd; pp. 117-131.
10. Eerdekens M, Karcher K, Grossman F, Kramer M (2003). Risperidone monotherapy in acute bipolar mania. Poster presented at World Psychiatric Association, Vienna, Austria, June 18-21, 2003.
11. Francis A, Docherty JP, Khan DA (1996). The expert consensus guidelines series: treatment of bipolar disorder. J Clin Psychiatry 57 (suppl 12A):S11-S18.
12. Gelenberg AJ, Hopkins HS (1996). Antipsychotics in bipolar disorder. J Clin Psychiatry 57 (suppl 9):S49-S52.
13. Gitlin MJ, Swendsen J, Heller TL, Hammen C (1995). Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635-1640.
14. Goldberg JF, Harrow M, Grossman LS (1995). Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 152:379-384.
15. Goodwin GM, for the Consensus Group of the British Association of Psychopharmacology (2003). Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149-173.
16. Harrow M, Goldberg JF, Grossman LS, Meltzer HY (1990). Outcome of manic disorder: a naturalistic follow-up study. Arch Gen Psychiatry 47:665-671.
17. Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C (2000). Gender and bipolar illness. J Clin Psychiatry 61:393-397.
18. Hirschfeld RMA, Bowden CL, Gitlin MJ, Keck PE, Suppes T, Thase ME (2002a). Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Am J Psychiatry 159:1-50.
19. Hirschfeld R, Keek PE, Karcher K, Kramer M, Grossman F, Vieta E, et al. (2002b). Rapid antimanic effect of risperidone monotherapy: a 3-week multicentre, double-blind, placebo-controlled trial. Poster presented at the 41st annual meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico, 8-12 December.
20. Johnstone EC, Crow TJ, Frith CD, Owens DG (1988). The Northwick Park 'Functional' Psychosis Study: diagnosis and treatment response. Lancet 2:119-125.
21. Keck PE, McElroy SL, Strakowski SM, Balisteri TM, Kizer HI, West SA (1996). Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 57:147-151.
22. Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. (2003). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160:1651-1658.
23. Keck PE, Versiani M, Potkin S, West SA, Giler E, Ice K and the Ziprasidone in Mania Study Group (2003). Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160:741-748.
24. Khanna S, Vieta E, Lyons B, Grossman F, Kramer M (2003). Risperidone in the treatment of acute bipolar mania: a double-blind, placebo-controlled study of 290 patients. Poster presented at 16th congress of the European College of Neuropsychopharmacology (ECNP), Prague, Czech Republic, September 2003.
25. Laska E, Verga E, Wanderling J, Simpson G, Logemann GW, Shah BK (1973). Patterns of psychotropic drug use for schizophrenia. Dis Nerv System 34:294-305.
26. Leibenluft E (1996). Women with bipolar illness: clinical and research issues. Am J Psychiatry 153:163-173.
27. Licht RW (1998). Drug treatment of mania: a critical review. Acta Psychiatrica Scand 97:387-397.
28. Licht RW, Gouliaev G, Vestergaard P, Dybbro J, Lund H, Merinder L (1994). Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 32:179-185.
29. McElroy SL, Keck PE, Strakowski SM (1996). Mania, psychosis and antipsychotics. J Clin Psychiatry 57 (suppl 3):S14-S26.
30. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Doherty JP (2000). The Expert Consensus Guideline Series: medication treatment of bipolar disorder. Postgrad Med Spec Iss 1:1-104.
31. Segal J, Berk M, Brook S (1998). Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 21:176-180.
32. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexley BE, Woods SW (1994). Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 151:133-135.
33. Soares JC, Mallinger AG, Gerson S (1997). The role of antipsychotics in the treatment of bipolar disorder patients. Int Clin Psychopharmacol 12:65-76.
34. Tohen M, Waternaux CM, Tsuang MT (1990). Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47:1106-1111.
35. Tohen M, Zarate CA (1998). Antipsychotic agents and bipolar disorder. J Clin Psychiatry 59 (suppl 1):S38-S48.
36. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengapp KNR, Daneil DG, et al. (1999). Olanzapine Versus Placebo in the Treatment of Acute Mania. Olanzapine HGEH Study Group. Am J Psychiatry 156:702-709.
37. Tohen M, Hennan J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, et al. (2000). Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 157:220-228.
38. Tohen M, Goldberg JF, Gonzalez-Pinto A, Azorin JM, Vieta E, Hardy-Bayle M, et al. (2003a). 12-week, double-blind comparison of olanzapine versus haloperidol in the treatment of acute mania. Arch Gen Psychiatry 60:1218-1226.
39. Tohen M, Zarate CA, Hennen J, Khalsa H-MK, Strakowski SM, Gebre-Medhin P, et al. (2003b). The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence. Am J Psychiatry 160:2099-2107.
40. Verdoux H, Bourgeois M (1993). A comparison of manic subgroups. Affect Disorders 27:267-272.